Nabi Biopharmaceuticals SWOT

  • December 2011
  • -
  • MarketLine

examines the firm ’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Nabi Biopharmaceuticals (Nabi) is engaged in the development of products that target medical conditions in the areas of nicotine addiction and infectious diseases. The industry player has a product pipeline focused on significant industry opportunities where current treatment options are inadequate, such as drug-resistant gram-positive infections and nicotine addiction. Nabi is headquartered in Rockville, Maryland and employed 42 people as of December 2009. The industry player recorded sales of USD 10.5 million during the financial year (FY) ended December 2009, and it did not record sales in FY2008. The operating loss of the industry player was USD 18.7 million as compared to an operating loss of USD 25.8 million in FY2008. The net loss was USD 18.7 million in FY2009 as compared to a net loss of USD 18.7 million in FY2008.

What's Included In This Report?

- Provides all the crucial information on Nabi Biopharmaceuticals required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Nabi Biopharmaceuticals in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Nabi Biopharmaceuticals
-Data is supplemented with details on Nabi Biopharmaceuticals history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Nabi Biopharmaceuticals

Why Should You Buy This Report?

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date industry player information available

Table Of Contents

Table of Contents:

SWOT COMPANY PROFILE: Nabi Biopharmaceuticals
Facts and Figures : Nabi Biopharmaceuticals
Corporate Description : Nabi Biopharmaceuticals
Business Overview : Nabi Biopharmaceuticals
Company History: Nabi Biopharmaceuticals
Top Executives : Nabi Biopharmaceuticals
Resumees : Nabi Biopharmaceuticals
Business Lines (products and services) : Nabi Biopharmaceuticals
Products and Services Analysis: Nabi Biopharmaceuticals
Strategic analysis (SWOT) : Nabi Biopharmaceuticals
*Strengths: Nabi Biopharmaceuticals
*Weaknesses: Nabi Biopharmaceuticals
*Opportunities: Nabi Biopharmaceuticals
*Threats: Nabi Biopharmaceuticals
Company View: Nabi Biopharmaceuticals
Competitive Landscape : Nabi Biopharmaceuticals
Subsidiary : Nabi Biopharmaceuticals
*Head Office: Nabi Biopharmaceuticals
*Other Locations and Subsidiaries: Nabi Biopharmaceuticals

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Bristol-Myers Squibb Company - Product Pipeline Review - 2014

Bristol-Myers Squibb Company - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

Bristol-Myers Squibb Company - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Bristol-Myers Squibb Company - Product Pipeline Review - 2014', provides an overview of the Bristol-Myers ...

Pfenex Inc. - Product Pipeline Review - 2014

Pfenex Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • July 2014
  • by Global Markets Direct

Pfenex Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Pfenex Inc. - Product Pipeline Review - 2014', provides an overview of the Pfenex Inc.'s pharmaceutical research and development ...

Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2014

Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • July 2014
  • by Global Markets Direct

Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Genervon Biopharmaceuticals, LLC - Product Pipeline Review - 2014', provides an overview of the Genervon ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.